Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hodgkin Disease × Bendamustine Hydrochloride × Clear all

Status

Sponsor Class

Study Type

Interventional 25 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1

Interventions

Psychiatric Rehabilitation 6 Therapeutics 4 Surveys and Questionnaires 4 Respiratory Physiological Phenomena 3 Polymerase Chain Reaction 3 Flow Cytometry 3 Blood Specimen Collection 3 Amplified Fragment Length Polymorphism Analysis 3 Watchful Waiting 2 RTEL1 protein, human 2 High-Energy Shock Waves 2 Exercise Test 2 Database Management Systems 2 Valganciclovir 1 Spectroscopy, Near-Infrared 1 Range of Motion, Articular 1 Radiotherapy 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Patient Health Questionnaire 1 Microarray Analysis 1 Inositol 1 Immunohistochemistry 1 Immunoenzyme Techniques 1 Immune Checkpoint Inhibitors 1 Heparin 1 Gene Rearrangement 1 Gene Expression Profiling 1 Ganciclovir 1 Foscarnet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145125 2025-11-21

HL-R2-B2

University Hospital, Bordeaux

Hodgkin Disease, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡